C T Ravirajan
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research 22
- Immunology top 5%
- T-cell and B-cell Immunology 18
- Immune Cell Function and Interaction 3
- Phagocytosis and Immune Regulation 2
-
- Monoclonal and Polyclonal Antibodies Research 26
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 5
- Hematology top 10%
- Platelet Disorders and Treatments 2
-
- Erythrocyte Function and Pathophysiology 2
- Co-authors
- David IsenbergAnisur RahmanJosé Delgado AlvesLee StanyerPaul R. J. AmesSean DonohueJatinderpal KalsiLesley Mason
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
C T Ravirajan
34 papers receiving 927 citations
Peers
Comparison fields: 5 of 59
- Rheumatology 621
- Immunology 624
- Radiology, Nuclear Medicine and Imaging 416
- Nephrology 112
- Hematology 100
Countries citing papers authored by C T Ravirajan
This map shows the geographic impact of C T Ravirajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C T Ravirajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C T Ravirajan more than expected).
Fields of papers citing papers by C T Ravirajan
This network shows the impact of papers produced by C T Ravirajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C T Ravirajan. The network helps show where C T Ravirajan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C T Ravirajan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 4 | |
| 2 | 2004 | 3 | |
| 3 | 2004 | 2 | |
| 4 | 2004 | 80 | |
| 5 | 2004 | 41 | |
| 6 | 2003 | 4 | |
| 7 | 2002 | 155 | |
| 8 | 2002 | 3 | |
| 9 | 2001 | 95 | |
| 10 | 2000 | 17 | |
| 11 | 1999 | 28 | |
| 12 | 1999 | 10 | |
| 13 | Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. | 1998 | 38 |
| 14 | 1998 | 66 | |
| 15 | 1997 | 18 | |
| 16 | 1997 | 33 | |
| 17 | 1996 | 46 | |
| 18 | 1995 | 6 | |
| 19 | 1995 | 14 | |
| 20 | 1991 | 14 |
About C T Ravirajan
C T Ravirajan is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 34 papers that have together received 946 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (26 papers), Systemic Lupus Erythematosus Research (22 papers), T-cell and B-cell Immunology (18 papers), Renal Diseases and Glomerulopathies (5 papers), Immune Cell Function and Interaction (3 papers), Phagocytosis and Immune Regulation (2 papers), Platelet Disorders and Treatments (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Rheumatology (621 citations), Immunology (624 citations) and Radiology, Nuclear Medicine and Imaging (416 citations). C T Ravirajan has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include David Isenberg, Anisur Rahman, José Delgado Alves, Lee Stanyer, Paul R. J. Ames, Sean Donohue, Jatinderpal Kalsi, Lesley Mason, Chaim Putterman and Valerio Pittoni.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.